ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

ClinicalTrials.gov ID: NCT07287982

Public ClinicalTrials.gov record NCT07287982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 12:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Double-Blinded, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Study identification

NCT ID
NCT07287982
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
argenx
Industry
Enrollment
60 participants

Conditions and interventions

Interventions

  • ARGX-119 IV Biological
  • Placebo IV Other

Biological · Other

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2025
Primary completion
May 27, 2029
Completion
May 27, 2029
Last update posted
Apr 21, 2026

2025 – 2029

United States locations

U.S. sites
17
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202 Recruiting
Rady Childrens Hospital San Diego California 92123 Not yet recruiting
Stanford University Medical Center Stanford California 94305 Not yet recruiting
Connecticut Children's Medical Center Hartford Connecticut 06106 Not yet recruiting
Rare Disease Research FL LLC Kissimmee Florida 34746 Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 Not yet recruiting
University of Iowa Stead Family Children's Hospital Iowa City Iowa 52242 Not yet recruiting
The Johns Hopkins Hospital Baltimore Maryland 21205 Not yet recruiting
Boston Children's Hospital Boston Massachusetts 02115 Not yet recruiting
The Curators of the University of Missouri on behalf of University of Missouri Health Care Columbia Missouri 65212 Not yet recruiting
Columbia University Herbert Irving Comprehensive Cancer Center New York New York 10032 Not yet recruiting
Rare Disease Research NC, LLC Hillsborough North Carolina 27278 Recruiting
Children's Hospital Philadelphia - Neurology Philadelphia Pennsylvania 19104 Not yet recruiting
St. Jude Children's Research Hospital Memphis Tennessee 38105 Not yet recruiting
Neurology Rare Disease Center Flower Mound Texas 75028 Recruiting
Texas Children's Hospital Houston Texas 77030 Not yet recruiting
Childrens Hospital of The Kings Daughters Norfolk Virginia 23507 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07287982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07287982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →